Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87267 refers to a laboratory test specifically designed for the detection of enterovirus antigens using the direct fluorescent antibody (DFA) technique. This test is crucial for identifying the presence of enteroviruses, which are small RNA viruses belonging to the picornaviridae family. Enteroviruses encompass a variety of species and serotypes, including well-known pathogens such as poliovirus, coxsackievirus, and echovirus. These viruses can lead to a range of clinical manifestations, particularly in infants and young children, who are most susceptible to infections. Common illnesses associated with non-polio enteroviruses include mild respiratory infections, hand, foot, and mouth disease, conjunctivitis, aseptic meningitis, encephalitis, myocarditis, pericarditis, acute flaccid paralysis, inflammatory muscle disease, and severe neonatal sepsis-like disease. The testing process involves obtaining respiratory samples through methods such as nasopharyngeal swabs, aspirates, or washings, as well as fecal samples via rectal swabs or stool sampling. Once collected, the samples are treated with enterovirus antibodies that are conjugated to fluorescein isothiocyanate. This allows for visualization under an epifluorescence microscope. If enterovirus antigens are present in the sample, the antibodies will bind to them, resulting in a bright green fluorescence in the nuclei of infected cells, while non-infected cells will exhibit a dull red coloration. Although this DFA technique is relatively rapid, yielding results within 2-3 hours, it is important to note that it is less sensitive compared to the reverse transcription-polymerase chain reaction (RT-PCR) method, which is another diagnostic approach for detecting enteroviruses.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 87267 is indicated for the detection of enterovirus antigens in patients presenting with symptoms or conditions associated with enterovirus infections. The following are specific indications for performing this test:
The procedure for the CPT® Code 87267 involves several critical steps to ensure accurate detection of enterovirus antigens. The first step is the collection of appropriate samples, which can be either respiratory or fecal. For respiratory samples, a nasopharyngeal swab, aspirate, or washing is performed to obtain the specimen. In the case of fecal samples, a rectal swab or stool sampling is utilized. Once the samples are collected, they are processed in the laboratory. Next, the samples are inoculated with enterovirus antibodies that are conjugated to fluorescein isothiocyanate. This conjugation is essential as it allows for the visualization of the enterovirus antigens under an epifluorescence microscope. The samples are then examined using this specialized microscope. If enterovirus antigens are present, the antibodies will bind to them, resulting in a bright green fluorescence in the nuclei of the infected cells. In contrast, non-infected surrounding cells will stain a dull red color, allowing for differentiation between infected and non-infected cells. This visual confirmation is crucial for the accurate diagnosis of enterovirus infections. The entire process is relatively rapid, with results typically available within 2-3 hours, although it is important to note that this method is less sensitive than the reverse transcription-polymerase chain reaction (RT-PCR) technique.
After the completion of the procedure associated with CPT® Code 87267, the laboratory will analyze the samples and report the findings. The expected turnaround time for results is approximately 2-3 hours, which allows for timely clinical decision-making. It is important for healthcare providers to interpret the results in conjunction with the patient's clinical presentation and history. If enterovirus antigens are detected, appropriate clinical management and follow-up care should be initiated based on the specific symptoms and conditions presented by the patient. Additionally, healthcare professionals should remain aware that while the DFA technique provides rapid results, it may not be as sensitive as other methods such as RT-PCR, and further testing may be warranted in certain cases.
| Short Descr | ENTEROVIRUS ANTIBODY DFA | Medium Descr | IAADI ENTEROVIRUS DIRECT FLUORESCENT ANTIBODY | Long Descr | Infectious agent antigen detection by immunofluorescent technique; Enterovirus, direct fluorescent antibody (DFA) | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| 2003-01-01 | Added | First appearance in code book in 2003. |
Get instant expert-level medical coding assistance.